Spero Therapeutics, Inc. (SPRO) › Shareholders' EquitySpero Therapeutics, Inc. (SPRO) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2016: -$45.44M2017: $84.60M2018: $115.50M2019: $74.57M2020: $132.04M2021: $88.29M2022: $75.93M2023: $106.89M2024: $46.12M2025: $59.02M$59.02M2016Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$59.02M+28.0%2024$46.12M-56.9%2023$106.89M+40.8%2022$75.93M-14.0%2021$88.29M-33.1%2020$132.04M+77.1%2019$74.57M-35.4%2018$115.50M+36.5%2017$84.60M+286.2%2016-$45.44M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share